| Matthew David Ellington, MD | |
|
1301 Barbara Jordan Blvd, Suite 300, Austin, TX 78723-3077 | |
| (512) 478-8116 | |
| (512) 478-9368 |
| Full Name | Matthew David Ellington |
|---|---|
| Gender | Male |
| Speciality | Orthopaedic Surgery - Pediatric Orthopaedic Surgery |
| Location | 1301 Barbara Jordan Blvd, Austin, Texas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013237080 | NPI | - | NPPES |
| 3581332-01 | Medicaid | TX | |
| 3581332-02 | Medicaid | TX | |
| 3581332-04 | Medicaid | TX | |
| 3581332-03 | Medicaid | TX |
| Entity Name | Central Texas Pediatric Orthopedics And Scoliosis Surgery Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144294661 PECOS PAC ID: 4183670367 Enrollment ID: O20050330001096 |
News Archive
At the world's largest conference on infectious diseases – the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) which opens today – a special Symposium on NMD-1 (New Delhi metallo-beta-lactamase) will focus on the implications of the increasing detection of this gene, which makes bacteria highly resistant to almost all known antibiotics. This is part of an alarming trend of antibiotic resistance that threatens to turn back the clock on years of progress following the discovery of antimicrobials, which revolutionised human health globally.
A randomized clinical trial of targeted, high-dose radiation for men with oligometastatic prostate cancer has shown the treatment to be an effective and safe option for patients who wish to delay hormone-suppression therapy.
A promising new antibiotic, moxifloxacin, produced by Bayer Healthcare is about to be tested against tuberculosis, a disease that kills 5,000 people a day.
University of Pennsylvania, in Philadelphia, PA has installed a MILabs U-SPECT+ system to advance several ongoing research topics. The U-SPECT+ delivers ultra-high resolution, sensitivity, and scanning speed yielding quantification results for brain, cardiac, cancer and musculoskeletal applications.
A research team from Weill Cornell Medical College and The Rockefeller University has identified a bacterium it believes may trigger multiple sclerosis, a chronic, debilitating disorder that damages myelin forming cells in the brain and spinal cord.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Matthew David Ellington, MD 1301 Barbara Jordan Blvd, Suite 300, Austin, TX 78723-3077 Ph: (512) 478-8116 | Matthew David Ellington, MD 1301 Barbara Jordan Blvd, Suite 300, Austin, TX 78723-3077 Ph: (512) 478-8116 |
News Archive
At the world's largest conference on infectious diseases – the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) which opens today – a special Symposium on NMD-1 (New Delhi metallo-beta-lactamase) will focus on the implications of the increasing detection of this gene, which makes bacteria highly resistant to almost all known antibiotics. This is part of an alarming trend of antibiotic resistance that threatens to turn back the clock on years of progress following the discovery of antimicrobials, which revolutionised human health globally.
A randomized clinical trial of targeted, high-dose radiation for men with oligometastatic prostate cancer has shown the treatment to be an effective and safe option for patients who wish to delay hormone-suppression therapy.
A promising new antibiotic, moxifloxacin, produced by Bayer Healthcare is about to be tested against tuberculosis, a disease that kills 5,000 people a day.
University of Pennsylvania, in Philadelphia, PA has installed a MILabs U-SPECT+ system to advance several ongoing research topics. The U-SPECT+ delivers ultra-high resolution, sensitivity, and scanning speed yielding quantification results for brain, cardiac, cancer and musculoskeletal applications.
A research team from Weill Cornell Medical College and The Rockefeller University has identified a bacterium it believes may trigger multiple sclerosis, a chronic, debilitating disorder that damages myelin forming cells in the brain and spinal cord.
› Verified 2 days ago
Michael W Burris, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 12201 Renfert Way, Suite 370, Austin, TX 78758 Phone: 512-617-1989 Fax: 512-617-2065 | |
Dr. William Parker Abblitt, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4700 Seton Center Pkwy Ste 200, Austin, TX 78759 Phone: 512-439-1000 | |
Ryan Michael Tibbetts, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 4700 Seton Center Pkwy, Ste 200, Austin, TX 78759 Phone: 512-439-1000 Fax: 512-439-1081 | |
Dr. Kevin J. Bozic, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1301 W 38th St, Ste 102, Austin, TX 78705 Phone: 512-454-4561 Fax: 512-406-7330 | |
Dr. Eugene P Schoch Iii, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 1015 East 32nd St, Suite 101, Austin, TX 78705 Phone: 512-477-6341 Fax: 512-477-1148 | |
Dr. Kathleen Dolores Rickert-madden, M.D. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 1301 Barbara Jordan Blvd Ste 300, Austin, TX 78723 Phone: 512-478-8116 Fax: 512-478-9368 |